| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 1174-1179, Copyright © 1993 by Endocrine Society
ARTICLES |
RS Goland, S Jozak, WB Warren, IM Conwell, RI Stark and PJ Tropper
Department of Medicine, Columbia University College of Physician and Surgeons, New York, New York 10032.
CRH is synthesized in the hypothalamus and released in response to stress into the portal hypophyseal blood; an additional site of synthesis, the placenta, is present only during pregnancy. Placental CRH is released into the maternal and fetal circulation during human pregnancy, and we hypothesized that the chronic fetal stress associated with fetal growth retardation may stimulate placental CRH release. We measured plasma CRH concentrations in the umbilical cord blood of 28 growth-retarded fetuses and 28 normally grown fetuses matched for gestational age and mode of delivery. Plasma ACTH, dehydroepiandrosterone sulfate (DHEAS), and cortisol were also measured in the umbilical cord samples to determine if CRH levels were correlated with levels of pituitary and adrenal hormones. The mean umbilical cord plasma CRH level in the growth-retarded fetuses was 206 +/- 25.8 pmol/L, which was significantly higher than that in the normally grown fetuses matched for gestational age, presence or absence of labor, and mode of delivery (49.4 +/- 16.7 pmol/L; P < 0.01). The mean plasma ACTH level in the growth-retarded fetuses (5.7 +/- 1.2 pmol/L) was significantly higher than that in the normally grown fetuses (3.3 +/- 0.7 pmol/L; P < 0.05). The mean cortisol concentration in the growth-retarded fetuses was 260 +/- 32.5 nmol/L, and that in the normally grown fetuses was 220 +/- 40 nmol/L. The mean DHEAS level was significantly lower in the growth-retarded fetuses (4.8 +/- 0.6 mumol/L) than that in the normally grown fetuses (7.7 +/- 0.6 mumol/L; P < 0.001). There was a significant correlation between umbilical cord plasma CRH and both ACTH and cortisol concentrations as well as a significant negative correlation between CRH and DHEAS levels in the growth-retarded fetuses. The umbilical cord plasma CRH level is extremely elevated in growth-retarded fetuses compared to that in normal fetuses. Placental CRH, like hypothalamic CRH, may be stimulated in conditions of chronic stress and may modulate fetal pituitary- adrenal function in high risk pregnancies.
This article has been cited by other articles:
![]() |
J. J. Volpe Cerebellum of the Premature Infant: Rapidly Developing, Vulnerable, Clinically Important J Child Neurol, September 1, 2009; 24(9): 1085 - 1104. [Abstract] [PDF] |
||||
![]() |
B. F. P. Broekman, Y.-H. Chan, Y.-S. Chong, S.-C. Quek, D. Fung, Y.-L. Low, Y.-P. Ooi, P. D. Gluckman, M. J. Meaney, T.-Y. Wong, et al. The Influence of Birth Size on Intelligence in Healthy Children Pediatrics, June 1, 2009; 123(6): e1011 - e1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Yim, L. M. Glynn, C. Dunkel Schetter, C. J. Hobel, A. Chicz-DeMet, and C. A. Sandman Risk of Postpartum Depressive Symptoms With Elevated Corticotropin-Releasing Hormone in Human Pregnancy Arch Gen Psychiatry, February 1, 2009; 66(2): 162 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rich-Edwards, A. P. Mohllajee, K. Kleinman, M. R. Hacker, J. Majzoub, R. J. Wright, and M. W. Gillman Elevated Midpregnancy Corticotropin-Releasing Hormone Is Associated with Prenatal, But Not Postpartum, Maternal Depression J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1946 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chan, E. H Rabbitt, B. A Innes, J. N Bulmer, P. M Stewart, M. D Kilby, and M. Hewison Glucocorticoid-induced apoptosis in human decidua: a novel role for 11{beta}-hydroxysteroid dehydrogenase in late gestation J. Endocrinol., October 1, 2007; 195(1): 7 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Rehman, R. Sirianni, C. R. Parker JR, W. E. Rainey, and B. R. Carr The Regulation of Adrenocorticotrophic Hormone Receptor by Corticotropin-Releasing Hormone in Human Fetal Adrenal Definitive/Transitional Zone Cells Reproductive Sciences, September 1, 2007; 14(6): 578 - 587. [Abstract] [PDF] |
||||
![]() |
R. Smith Parturition N. Engl. J. Med., January 18, 2007; 356(3): 271 - 283. [Full Text] [PDF] |
||||
![]() |
D. M. Sloboda, T. J. M. Moss, S. Li, D. Doherty, I. Nitsos, J. R. G. Challis, and J. P. Newnham Prenatal betamethasone exposure results in pituitary-adrenal hyporesponsiveness in adult sheep Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E61 - E70. [Abstract] [Full Text] [PDF] |
||||
![]() |
K A Neville and J L Walker Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity Arch. Dis. Child., March 1, 2005; 90(3): 258 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Drake, B. R. Walker, and J. R. Seckl Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R34 - R38. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. El-Haddad, M. Desai, D. Gayle, and M. G. Ross In Utero Development of Fetal Thirst and Appetite: Potential for Programming Reproductive Sciences, April 1, 2004; 11(3): 123 - 130. [Abstract] [PDF] |
||||
![]() |
B. Madhappan, D. Kempuraj, S. Christodoulou, S. Tsapikidis, W. Boucher, V. Karagiannis, A. Athanassiou, and T. C. Theoharides High Levels of Intrauterine Corticotropin-Releasing Hormone, Urocortin, Tryptase, and Interleukin-8 in Spontaneous Abortions Endocrinology, June 1, 2003; 144(6): 2285 - 2290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cleasby, P. A. T. Kelly, B. R. Walker, and J. R. Seckl Programming of Rat Muscle and Fat Metabolism by in Utero Overexposure to Glucocorticoids Endocrinology, March 1, 2003; 144(3): 999 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Thome, I. C. Davis, S. V. Nguyen, B. J. Shelton, and S. Matalon Modulation of sodium transport in fetal alveolar epithelial cells by oxygen and corticosterone Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L376 - L385. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, A. Goumenou, E. Koumantakis, E. W. Hillhouse, and D. K. Grammatopoulos Reduced Expression of Corticotropin-Releasing Hormone Receptor Type-1{alpha} in Human Preeclamptic and Growth-Restricted Placentas J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 363 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bolt, M. M. van Weissenbruch, C. Popp-Snijders, C. G. J. Sweep, H. N. Lafeber, and H. A. Delemarre-van de Waal Fetal Growth and the Function of the Adrenal Cortex in Preterm Infants J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1194 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D Byrne Programming other hormones that affect insulin: Type 2 diabetes Br. Med. Bull., November 1, 2001; 60(1): 153 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Blondeau, J. Lesage, P. Czernichow, J. P. Dupouy, and B. Breant Glucocorticoids impair fetal {beta}-cell development in rats Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E592 - E599. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Erickson, P. Thorsen, G. Chrousos, D. E. Grigoriadis, O. Khongsaly, J. McGregor, and J. Schulkin Preterm Birth: Associated Neuroendocrine, Medical, and Behavioral Risk Factors J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2544 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lesage, B. Blondeau, M. Grino, B. Bréant, and J. P. Dupouy Maternal Undernutrition during Late Gestation Induces Fetal Overexposure to Glucocorticoids and Intrauterine Growth Retardation, and Disturbs the Hypothalamo-Pituitary Adrenal Axis in the Newborn Rat Endocrinology, May 1, 2001; 142(5): 1692 - 1702. [Abstract] [Full Text] |
||||
![]() |
W.L. Whittle, F.A. Patel, N. Alfaidy, A.C. Holloway, M. Fraser, S. Gyomorey, S.J. Lye, W. Gibb, and J.R.G. Challis Glucocorticoid Regulation of Human and Ovine Parturition: The Relationship Between Fetal Hypothalamic-Pituitary-Adrenal Axis Activation and Intrauterine Prostaglandin Production Biol Reprod, April 1, 2001; 64(4): 1019 - 1032. [Abstract] [Full Text] |
||||
![]() |
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death PNAS, December 8, 2000; (2000) 260501697. [Abstract] [Full Text] |
||||
![]() |
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye Endocrine and Paracrine Regulation of Birth at Term and Preterm Endocr. Rev., October 1, 2000; 21(5): 514 - 550. [Abstract] [Full Text] |
||||
![]() |
P C Ng The fetal and neonatal hypothalamic-pituitary-adrenal axis Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2000; 82(3): 250F - 254. [Full Text] |
||||
![]() |
T. Simoncini, R. Apa, F. M. Reis, F. Miceli, M. Stomati, L. Driul, A. Lanzone, A. R. Genazzani, and F. Petraglia Human Umbilical Vein Endothelial Cells: A New Source and Potential Target for Corticotropin-Releasing Factor J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2802 - 2806. [Abstract] [Full Text] |
||||
![]() |
R. Gagnon, J. Langridge, K. Inchley, J. Murotsuki, and F. Possmayer Changes in surfactant-associated protein mRNA profile in growth-restricted fetal sheep Am J Physiol Lung Cell Mol Physiol, March 1, 1999; 276(3): L459 - L465. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Giussani, J. A. Winter, S. L. Jenkins, J. D. Tame, L. M. Abrams, X.-Y. Ding, and P. W. Nathanielsz Changes in Fetal Plasma Corticotropin-Releasing Hormone during Androstenedione-Induced Labor in the Rhesus Monkey: Lack of an Effect on the Fetal Hypothalamo-Pituitary-Adrenal Axis Endocrinology, June 1, 1998; 139(6): 2803 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Lindsay, R. M. Lindsay, C. R.W. Edwards, and J. R. Seckl Inhibition of 11ß-Hydroxysteroid Dehydrogenase in Pregnant Rats and the Programming of Blood Pressure in the Offspring Hypertension, June 1, 1996; 27(6): 1200 - 1204. [Abstract] [Full Text] |
||||
![]() |
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death PNAS, December 19, 2000; 97(26): 14726 - 14730. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |